Analyst Reco. Guardant Health, Inc.

Equities

GH

US40131M1099

Market Closed - Nasdaq Other stock markets 21:00:00 02/05/2024 BST			5-day change	1st Jan Change
18.58 ^USD	+1.75%		+8.28%	-31.31%

04-29	Canaccord Genuity Adjusts Price Target on Guardant Health to $30 From $45, Maintains Buy Rating	MT
04-22	Sector Update: Health Care Stocks Increase Late Afternoon	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Canaccord Genuity Adjusts Price Target on Guardant Health to $30 From $45, Maintains Buy Rating	04-29	MT
Goldman Sachs Adjusts Guardant Health Price Target to $28 From $32, Maintains Buy Rating	04-15	MT
Piper Sandler Cuts Price Target on Guardant Health to $30 From $40, Maintains Overweight Rating	02-26	MT
UBS Adjusts Guardant Health Price Target to $32 From $45, Maintains Buy Rating	02-23	MT
Canaccord Genuity Adjusts Price Target on Guardant Health to $45 From $50, Maintains Buy Rating	02-23	MT
Goldman Sachs Cuts Price Target on Guardant Health to $37 From $43, Maintains Buy Rating	01-29	MT
Raymond James Upgrades Guardant Health to Outperform From Market Perform, Price Target is $27	11-13	MT
Morgan Stanley Cuts Price Target on Guardant Health to $50 From $55, Keeps Overweight Rating	11-08	MT
UBS Adjusts Guardant Health Price Target to $45 From $44, Maintains Buy Rating	11-07	MT
Goldman Sachs Cuts Price Target on Guardant Health to $45 From $52, Keeps Buy Rating	23/10/23	MT
BofA Securities Adjusts Price Target on Guardant Health to $46 From $57, Maintains Buy Rating	20/10/23	MT
Goldman Sachs Lowers Price Target on Guardant Health to $45 From $52, Maintains Buy Rating	20/10/23	MT
Guardant Health Shares Climb After Bernstein Initiates Coverage With Outperform Rating	28/09/23	MT
Bernstein Starts Guardant Health With Outperform Rating	28/09/23	MT
Piper Sandler Upgrades Guardant Health to Overweight From Neutral	27/09/23	MT
UBS Adjusts Guardant Health Price Target to $44 From $43, Maintains Buy Rating	08/08/23	MT
Morgan Stanley Adjusts Guardant Health's Price Target to $55 From $60, Keeps Overweight Rating	07/08/23	MT
Citigroup Adjusts Guardant Health's Price Target to $50 From $40, Keeps Buy Rating	04/08/23	MT
Citigroup Upgrades Guardant Health to Buy From Neutral, Adjusts Price Target to $40 From $28	26/05/23	MT
UBS Adjusts Guardant Health Price Target to $43 From $40, Maintains Buy Rating	12/05/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Guardant Health, Inc.

Equities

GH

US40131M1099

Analyst Reco.

Filters